| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.92 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,922,851 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,660,378 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
29 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Telling Fred |
Director |
– • – |
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
71,429 |
223,308 |
|
- |
|
| Love Richard L |
Director |
– • – |
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
71,429 |
263,510 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
89,286 |
298,415 |
|
- |
|
| Bauer John H |
Director |
– • – |
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
71,429 |
249,412 |
|
- |
|
| Gregorian Vartan |
Director |
– • – |
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
71,429 |
236,182 |
|
- |
|
| Philips Craig |
Former President |
– – – |
2012-11-19 |
4 |
S |
$1.25 |
$81,253 |
D/D |
(65,000) |
414 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2012-09-26 |
4 |
AS |
$2.44 |
$24,400 |
D/D |
(10,000) |
1,056,559 |
|
- |
|
| Philips Craig |
former President |
– – – |
2012-09-25 |
4 |
S |
$2.65 |
$92,663 |
D/D |
(35,000) |
132,646 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2012-09-20 |
4 |
S |
$2.66 |
$107,708 |
D/D |
(40,000) |
1,066,559 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2012-09-20 |
4 |
S |
$2.68 |
$40,200 |
D/D |
(15,000) |
354,350 |
|
- |
|
| Telling Fred |
Director |
– • – |
2012-09-18 |
4 |
S |
$2.85 |
$53,913 |
D/D |
(18,874) |
151,879 |
|
- |
|
| Philips Craig |
former president |
– – – |
2012-09-17 |
4 |
S |
$2.93 |
$87,902 |
D/D |
(30,000) |
167,839 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2012-08-31 |
4 |
AS |
$0.43 |
$21,500 |
D/D |
(50,000) |
5,532,806 |
|
- |
|
| Philips Craig |
former President |
– – – |
2012-08-27 |
4 |
S |
$0.44 |
$76,258 |
D/D |
(175,000) |
814,197 |
|
- |
|
| Eramian Daniel G |
EVP, Corporate Communications |
• – – |
2012-08-24 |
4 |
S |
$0.39 |
$37,213 |
D/D |
(95,000) |
1,846,761 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2012-08-23 |
4 |
S |
$0.40 |
$48,012 |
D/D |
(120,000) |
2,212,969 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2012-08-22 |
4 |
S |
$0.40 |
$97,922 |
D/D |
(244,805) |
5,582,806 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2012-08-17 |
4 |
S |
$0.40 |
$9,002 |
D/D |
(22,267) |
2,332,969 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2012-08-16 |
4 |
S |
$0.40 |
$11,030 |
D/D |
(27,733) |
2,355,236 |
|
- |
|
| Philips Craig |
former President |
– – – |
2012-08-15 |
4 |
S |
$0.40 |
$69,929 |
D/D |
(175,000) |
989,197 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2012-08-10 |
4 |
S |
$0.42 |
$21,100 |
D/D |
(50,000) |
5,827,611 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2012-08-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
46,535 |
354,644 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2012-07-30 |
4 |
AS |
$0.51 |
$25,400 |
D/D |
(50,000) |
5,877,611 |
|
- |
|
| Philips Craig |
President |
• – – |
2012-06-29 |
4 |
S |
$0.56 |
$52,594 |
D/D |
(92,000) |
3,931,669 |
|
- |
|
742 Records found
|
|
Page 13 of 30 |
|
|
